Corcept Therapeutics Inc
CORT· Nasdaq
Released Aug 1, 2017, after the close
10-Q filed Aug 2, 2017, 33 days after period end · 0001564590-17-014705
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $35.56M | $19.72M | $11.96M | $5.85M |
| Net Income | $12.65M | $977.00K | -$1.94M | -$7.55M |
| EPS Diluted | $0.10 |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.01 |
| -$0.02 |
| -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.